InvestorsHub Logo
Followers 743
Posts 61848
Boards Moderated 10
Alias Born 10/05/2009

Re: boomer0921 post# 18224

Monday, 03/08/2021 11:48:24 AM

Monday, March 08, 2021 11:48:24 AM

Post# of 20017
It's a complex SEC set of regs, partly, over my pay grade. My experts say the new shares must all be seasoned for a year after it goes back to SEC reporting. There is no way this stays on OTC.

Also there may be say 10 bag holders holding 10% each of the new AS shares, that can not be sold with out SEC filings/and pre-arranged Liquidation plans. If they even plan to sell any after a year.

The kind of people that funded this company are use to holding for a decade or more...Keystone Nano was Private for 15 years.

My best Guess is they get more money up front with Licensing deals early on, but if they wanted to raise a lot of cash for the long haul they shove the stock price way past $100/share and then raise really cheap money at $100/share for any kind of Phase III drug trials.

Or they license it out to folks like NVS-Novartis who have a 300 Billion dollar market cap and world wide distribution infrastructure for Rx drugs....

They could end up with dozens of licenses and deals!!! Each worth billions over time.